Several vignettes are presented that illustrate approaches to use genome-wide association studies results to clarify AD-related pathways and potential therapeutics.
This work investigated brain transcriptomic landscapes to gain insights into shared and divergent molecular and biological etiologies across LOAD and MDD.
Michael W. Lutz, Zhao-Hui Man, O. Chiba-Falek· Alzheimer's & Dementia· 0 citations
The impact of CKD transcriptional risk on AD endophenotypes is assessed by assessing the impact of CKD transcriptional risk on AD endophenotypes in individuals with chronic kidney disease.
Jung-Min Pyun, Young Ho Park, Jiyun Hwang et al.· Alzheimer's & Dementia· 0 citations
A heteroscedastic personalized regression framework is introduced to move beyond cohort-averaged associations and construct individualized single-nucleotide polymorphism (SNP) profiles for each subject, showing that model-derived individualized SNP-score profiles can reveal latent structure associated with cognitive an...
The current understanding of the genetic and physiological mechanisms underlying Alzheimer’s disease is reviewed and modern approaches for diagnosis and treatment are discussed.
Zahraa Mohammed Fakheir, S. A. H. Jasim· Journal of Genetic and Envir...· 0 citations
An expanding body of evidence suggests that thyroid dysfunction may be clinically relevant in Alzheimer's disease (AD), although the significance of this association remains unsettled. Rather than reflecting a single biological pathway, thyroid hormone alterations in AD may involve downstream systemic adaptations relat...
Alfonso Ilardi, C. Ilardi· Journal of Alzheimer's Disea...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.